Sign Up to like & get
recommendations!
1
Published in 2019 at "Nature Reviews Nephrology"
DOI: 10.1038/s41581-019-0171-2
Abstract: Inhibitors of sodium–glucose cotransporter 2 (SGLT2) and dipeptidyl peptidase 4 (DPP4) are widely used in patients with type 2 diabetes to improve glycaemic control and reduce cardiovascular risks. Two recent clinical trials, CREDENCE and DELIGHT,…
read more here.
Keywords:
nephrology;
delight deliver;
credence;
credence delight ... See more keywords